Pentamer staining in CRC patients and their donors
. | % CEA-Cap1+/CD8+ cells . | . | . | . | |||
|---|---|---|---|---|---|---|---|
| ID no. . | Patient* . | Sibling donor . | Before GVHD . | During GVHD . | |||
| 8 | 0.05 | 0.32 | 0.14 | 1.71 | |||
| 11 | 0.08 | 0.19 | 0.21 | 1.79 | |||
| 12 | 0.10 | 0.24 | 0.05 | 0.81 | |||
| 3 | 0.04 | 0.05 | 0.14 | NA | |||
| 7 | 0.25 | 0.11 | 0.33 | NA | |||
| 9 | 0.14 | 0.02 | 0.02 | NA | |||
. | % CEA-Cap1+/CD8+ cells . | . | . | . | |||
|---|---|---|---|---|---|---|---|
| ID no. . | Patient* . | Sibling donor . | Before GVHD . | During GVHD . | |||
| 8 | 0.05 | 0.32 | 0.14 | 1.71 | |||
| 11 | 0.08 | 0.19 | 0.21 | 1.79 | |||
| 12 | 0.10 | 0.24 | 0.05 | 0.81 | |||
| 3 | 0.04 | 0.05 | 0.14 | NA | |||
| 7 | 0.25 | 0.11 | 0.33 | NA | |||
| 9 | 0.14 | 0.02 | 0.02 | NA | |||
NA indicates not applicable (no GVHD).
Colon cancer patients analyzed before transplantation